Antibiotics for acute bronchitis - PubMed
- ️Sun Jan 01 2017
Review
Antibiotics for acute bronchitis
Susan M Smith et al. Cochrane Database Syst Rev. 2017.
Abstract
Background: The benefits and risks of antibiotics for acute bronchitis remain unclear despite it being one of the most common illnesses seen in primary care.
Objectives: To assess the effects of antibiotics in improving outcomes and to assess adverse effects of antibiotic therapy for people with a clinical diagnosis of acute bronchitis.
Search methods: We searched CENTRAL 2016, Issue 11 (accessed 13 January 2017), MEDLINE (1966 to January week 1, 2017), Embase (1974 to 13 January 2017), and LILACS (1982 to 13 January 2017). We searched the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) and ClinicalTrials.gov on 5 April 2017.
Selection criteria: Randomised controlled trials comparing any antibiotic therapy with placebo or no treatment in acute bronchitis or acute productive cough, in people without underlying pulmonary disease.
Data collection and analysis: At least two review authors extracted data and assessed trial quality.
Main results: We did not identify any new trials for inclusion in this 2017 update. We included 17 trials with 5099 participants in the primary analysis. The quality of trials was generally good. At follow-up there was no difference in participants described as being clinically improved between the antibiotic and placebo groups (11 studies with 3841 participants, risk ratio (RR) 1.07, 95% confidence interval (CI) 0.99 to 1.15). Participants given antibiotics were less likely to have a cough (4 studies with 275 participants, RR 0.64, 95% CI 0.49 to 0.85; number needed to treat for an additional beneficial outcome (NNTB) 6) and a night cough (4 studies with 538 participants, RR 0.67, 95% CI 0.54 to 0.83; NNTB 7). Participants given antibiotics had a shorter mean cough duration (7 studies with 2776 participants, mean difference (MD) -0.46 days, 95% CI -0.87 to -0.04). The differences in presence of a productive cough at follow-up and MD of productive cough did not reach statistical significance.Antibiotic-treated participants were more likely to be improved according to clinician's global assessment (6 studies with 891 participants, RR 0.61, 95% CI 0.48 to 0.79; NNTB 11) and were less likely to have an abnormal lung exam (5 studies with 613 participants, RR 0.54, 95% CI 0.41 to 0.70; NNTB 6). Antibiotic-treated participants also had a reduction in days feeling ill (5 studies with 809 participants, MD -0.64 days, 95% CI -1.16 to -0.13) and days with impaired activity (6 studies with 767 participants, MD -0.49 days, 95% CI -0.94 to -0.04). The differences in proportions with activity limitations at follow-up did not reach statistical significance. There was a significant trend towards an increase in adverse effects in the antibiotic group (12 studies with 3496 participants, RR 1.20, 95% CI 1.05 to 1.36; NNT for an additional harmful outcome 24).
Authors' conclusions: There is limited evidence of clinical benefit to support the use of antibiotics in acute bronchitis. Antibiotics may have a modest beneficial effect in some patients such as frail, elderly people with multimorbidity who may not have been included in trials to date. However, the magnitude of this benefit needs to be considered in the broader context of potential side effects, medicalisation for a self limiting condition, increased resistance to respiratory pathogens, and cost of antibiotic treatment.
Conflict of interest statement
Susan M Smith: None known. Tom Fahey: None known. John Smucny: None known. Lorne A Becker: None known.
Figures
![1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/6481481/fb2c6b006aa6/nCD000245-AFig-FIG01.gif)
'Risk of bias' summary: review authors' judgements about each methodological quality item for each included study.
![2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/6481481/66a9d330f2c1/nCD000245-AFig-FIG02.gif)
'Risk of bias' graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.
![3](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/6481481/4db76f9301e8/nCD000245-AFig-FIG03.gif)
Forest plot of comparison: Cough at follow‐up visit, outcome: number of participants with cough.
![4](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/6481481/0f761809f602/nCD000245-AFig-FIG04.gif)
Forest plot of comparison: 8 Days of cough, outcome: mean number of days of cough.
![5](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/6481481/52e316d3706d/nCD000245-AFig-FIG05.gif)
Forest plot of comparison: Clinically improved, outcome: number of participants reporting no limitations or described as cured/well/symptoms resolved or globally improved.
![6](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/6481481/51c1fbaf4471/nCD000245-AFig-FIG06.gif)
Forest plot of comparison: Days of feeling ill, outcome: mean number of days of feeling ill.
![7](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/6481481/93829bdebd88/nCD000245-AFig-FIG07.gif)
Forest plot of comparison: Not improved by physician's global assessment at follow‐up visit, outcome: number of participants not improved.
![8](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a09/6481481/a09ca4d1c40c/nCD000245-AFig-FIG08.gif)
Forest plot of comparison: Number of participants with adverse effects.
Update of
-
Antibiotics for acute bronchitis.
Smith SM, Fahey T, Smucny J, Becker LA. Smith SM, et al. Cochrane Database Syst Rev. 2014 Mar 1;(3):CD000245. doi: 10.1002/14651858.CD000245.pub3. Cochrane Database Syst Rev. 2014. PMID: 24585130 Updated. Review.
Similar articles
-
Antibiotics for acute bronchitis.
Smith SM, Fahey T, Smucny J, Becker LA. Smith SM, et al. Cochrane Database Syst Rev. 2014 Mar 1;(3):CD000245. doi: 10.1002/14651858.CD000245.pub3. Cochrane Database Syst Rev. 2014. PMID: 24585130 Updated. Review.
-
Antibiotics for acute bronchitis.
Smucny J, Fahey T, Becker L, Glazier R. Smucny J, et al. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD000245. doi: 10.1002/14651858.CD000245.pub2. Cochrane Database Syst Rev. 2004. PMID: 15494994 Updated. Review.
-
Antibiotics for acute bronchitis.
Smucny J, Fahey T, Becker L, Glazier R, McIsaac W. Smucny J, et al. Cochrane Database Syst Rev. 2000;(4):CD000245. doi: 10.1002/14651858.CD000245. Cochrane Database Syst Rev. 2000. PMID: 11034678 Updated. Review.
-
Antibiotics for acute otitis media in children.
Venekamp RP, Sanders SL, Glasziou PP, Del Mar CB, Rovers MM. Venekamp RP, et al. Cochrane Database Syst Rev. 2015 Jun 23;2015(6):CD000219. doi: 10.1002/14651858.CD000219.pub4. Cochrane Database Syst Rev. 2015. PMID: 26099233 Free PMC article. Updated. Review.
-
Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P. Crider K, et al. Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
Cited by
-
[Acute and chronic cough-What is new?].
Kardos P. Kardos P. Pneumologe (Berl). 2020;17(6):433-442. doi: 10.1007/s10405-020-00346-1. Epub 2020 Oct 9. Pneumologe (Berl). 2020. PMID: 33071698 Free PMC article. German.
-
Acute cough in Italian children: parents' beliefs, approach to treatment, and the family impact.
Dal Negro RW, Zanasi A, Turco P, Povero M. Dal Negro RW, et al. Multidiscip Respir Med. 2019 Apr 4;14:16. doi: 10.1186/s40248-019-0180-9. eCollection 2019. Multidiscip Respir Med. 2019. PMID: 30988950 Free PMC article.
-
Little P, Francis NA, Stuart B, O'Reilly G, Thompson N, Becque T, Hay AD, Wang K, Sharland M, Harnden A, Yao G, Raftery J, Zhu S, Little J, Hookham C, Rowley K, Euden J, Harman K, Coenen S, Read RC, Woods C, Butler CC, Faust SN, Leydon G, Wan M, Hood K, Whitehurst J, Richards-Hall S, Smith P, Thomas M, Moore M, Verheij T. Little P, et al. Lancet. 2021 Oct 16;398(10309):1417-1426. doi: 10.1016/S0140-6736(21)01431-8. Epub 2021 Sep 22. Lancet. 2021. PMID: 34562391 Free PMC article. Clinical Trial.
-
[Acute Respiratory Tract Infections/Acute Bronchitis].
Kleibrink B, Taube C. Kleibrink B, et al. Dtsch Med Wochenschr. 2019 Feb;144(3):185-188. doi: 10.1055/a-0655-8058. Epub 2019 Jan 31. Dtsch Med Wochenschr. 2019. PMID: 30703838 Free PMC article. German.
-
Shi L, Chang J, Liu X, Zhai P, Hu S, Li P, Hayat K, Kabba JA, Feng Z, Yang C, Jiang M, Zhao M, Hu H, Fang Y. Shi L, et al. Antibiotics (Basel). 2020 Apr 6;9(4):163. doi: 10.3390/antibiotics9040163. Antibiotics (Basel). 2020. PMID: 32268530 Free PMC article.
References
References to studies included in this review
Brickfield 1986 {published data only}
-
- Brickfield FX, Carter WH, Johnson RE. Erythromycin in the treatment of acute bronchitis in a community practice. Journal of Family Practice 1986;23:119‐22. - PubMed
Dunlay 1987 {published data only}
-
- Dunlay J, Reinhardt R, Roi LD. A placebo‐controlled, double‐blind trial of erythromycin in adults with acute bronchitis. Journal of Family Practice 1987;25:137‐41. - PubMed
Evans 2002 {published data only}
-
- Evans AT, Husain S, Durairaj L, Sadowski LS, Charles‐Damte M, Wang Y. Azithromycin for acute bronchitis: a randomised, double‐blind, controlled trial. Lancet 2002;359:1648‐54. - PubMed
Franks 1984 {published data only}
-
- Franks P, Gleiner JA. The treatment of acute bronchitis with trimethoprim and sulfamethoxazole. Journal of Family Practice 1984;19:185‐90. - PubMed
Howie 1970 {published and unpublished data}
-
- Howie JGR, Clark GA. Double‐blind trial of early demethylchlortetracycline in minor respiratory illness in general practice. Lancet 1970;296(7683):1099‐102. - PubMed
Hueston 1994 {published and unpublished data}
-
- Hueston WJ. Albuterol delivered by metered‐dose inhaler to treat acute bronchitis. Journal of Family Practice 1994;39(5):437‐40. - PubMed
Kaiser 1996 {published and unpublished data}
-
- Kaiser L, Lew D, Hirschel B, Auckenthaler R, Morabia A, Heald A, et al. Effects of antibiotic treatment in the subset of common‐cold patients who have bacteria in nasopharyngeal secretions. Lancet 1996;347:1507‐10. - PubMed
King 1996 {published and unpublished data}
-
- King DE, Williams WC, Bishop L, Shechter A. Effectiveness of erythromycin in the treatment of acute bronchitis. Journal of Family Practice 1996;42:601‐5. - PubMed
Little 2005 {published and unpublished data}
-
- Little P, Rumsby K, Kelly J, Watson L, Moore M, Warner G, et al. Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection. JAMA 2005;293(24):3029‐35. - PubMed
Little 2013 {published and unpublished data}
-
- Little P, Stuart B, Moore M, Coenen S, Butler CB, Godyscki‐Cwirko M, et al. Amoxicillin for acute lower‐respiratory‐tract infection when pneumonia is not suspected: a 12 country, randomised, placebo‐controlled trial. Lancet Infectious Diseases 2013;13:123‐9. - PubMed
Llor 2013 {published data only}
Matthys 2000 {published data only}
-
- Matthys H, Mey C, Carls C, Rys A, Geib A, Wittig T. Efficacy and tolerability of myrtol standardised in acute bronchitis. Arzmeimittel Forschung 2000;50:700‐11. - PubMed
Nduba 2008 {published data only}
-
- Nduba VN, Mwachari CW, Magaret AS, Park DR, Kigo A, Hooton TM, et al. Placebo found equivalent to amoxicillin for treatment of acute bronchitis in Nairobi, Kenya: a triple blind, randomised equivalence study. Thorax 2008;63:999‐1005. - PubMed
Scherl 1987 {published data only}
-
- Scherl ER, Riegler SL, Cooper JK. Doxycycline in acute bronchitis: a randomized double‐blind trial. Journal of the Kentucky Medical Association 1987;85:539‐41. - PubMed
Stott 1976 {published data only}
Verheij 1994 {published data only}
Williamson 1984 {published and unpublished data}
-
- Williamson HA. A randomized controlled trial of doxycycline in the treatment of acute bronchitis. Journal of Family Practice 1984;19:481‐6. - PubMed
References to studies excluded from this review
Batieha 2002 {published data only}
-
- Batieha A, Yahia G, Mahafzeh T, Omari M, Momani A, Dabbas M. No advantage of treating acute respiratory tract infections with azithromycin in a placebo‐controlled trial. Scandinavian Journal of Infectious Diseases 2002;34(4):243‐7. - PubMed
Christ‐Crain 2004 {published data only}
-
- Christ‐Crain M, Jaccard‐Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, et al. Effect of procalcitonin‐guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster‐randomised, single‐blinded intervention trial. Lancet 2004;363(9409):600‐7. - PubMed
Dowell 2001 {published data only}
Gordon 1974 {published data only}
-
- Gordon M, Lovell S, Dugdale AE. The value of antibiotics in minor respiratory illness in children: a controlled trial. Medical Journal of Australia 1974;1:304‐6. - PubMed
Gottfarb 1994 {published data only}
-
- Gottfarb P, Brauner A. Children with persistent cough ‐ outcome with treatment and role of Moraxella catarrhalis. Scandinavian Journal of Infectious Diseases 1994;26:545‐51. - PubMed
Stephenson 1989 {unpublished data only}
-
- Stephenson MJ. Antibiotics for acute bronchitis: a randomised controlled trial. Unpublished data 1989.
Additional references
Ayres 1986
Boldy 1990
Butler 2010
-
- Butler CC, Hood K, Kelly MJ, Goossens H, Verheij T, Little P, et al. Treatment of acute cough/lower respiratory tract infection by antibiotic class and associated outcomes: a 13 European country observational study in primary care. Journal of Antimicrobial Chemotherapy 2010;65(11):2472‐8. - PubMed
CDC 2013
-
- Centers for Disease Control and Prevention. Overview of bronchitis. www.cdc.gov/getsmart/antibiotic‐use/uri/bronchitis.html 2013 (accessed 11 November 2013).
Coenen 2007
Dagnelie 1996
Del Mar 2016
-
- Mar C. Antibiotics for acute respiratory tract infections in primary care. BMJ 2016;354:i3482. - PubMed
Delozier 1989
-
- Delozier JE, Gagnon RO. National Ambulatory Care Survey 1989 Summary. Advanced Data No. 203. National Center for Health Statistics 1989; Vol. 203:1‐11. - PubMed
ECDC 2013
-
- European Centre for Disease Control. Trend of antimicrobial consumption by country. www.ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/esac‐net‐dat... 2013 (accessed 8 November 2013).
Falck 1994
-
- Falck G, Heyman L, Gnarpe J, Gnarpe H. Chlamydia pneumoniae (TWAR): a common agent in acute bronchitis. Scandinavian Journal of Infectious Diseases 1994;26:179‐87. - PubMed
Foy 1993
-
- Foy HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clinical Infectious Diseases 1993;17(Suppl 1):37‐46. - PubMed
Gonzales 1995
-
- Gonzales R, Sande M. What will it take to stop physicians from prescribing antibiotics in acute bronchitis?. Lancet 1995;345:665. - PubMed
Gonzales 1997
-
- Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997;278:901‐4. - PubMed
Grayston 1993
-
- Grayston JT, Aldous MB, Easton A, Wang SP, Kuo CC, Campbell LA, et al. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis. Journal of Infectious Diseases 1993;168:1231‐5. - PubMed
Gulliford 2011
Henry 1995
Herman 1984
-
- Herman JM. Patients' willingness to take risks in the management of pharyngitis. Journal of Family Practice 1984;6:767‐72. - PubMed
Herwaldt 1991
-
- Herwaldt LA. Pertussis in adults: what physicians need to know. Archives of Internal Medicine 1991;151:1510‐2. - PubMed
Hueston 1997
-
- Hueston WJ. Antibiotics: neither cost effective nor 'cough' effective. Journal of Family Practice 1997;44:261‐5. - PubMed
Jonsson 1997
-
- Jonsson JS, Sigurdsson JA, Kristinsson KG, Guonadottir M, Magnusson S. Acute bronchitis in adults: how close do we come to its aetiology in general practice?. Scandinavian Journal of Primary Health Care 1997;15:156‐60. - PubMed
Laurenzi 1961
-
- Laurenzi GA, Potter RT, Kass EH. Bacteriologic flora of the lower respiratory tract. New England Journal of Medicine 1961;265:1273‐8. - PubMed
Lefebvre 2011
-
- Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.
Macfarlane 1993
-
- Macfarlane JR, Colville A, Guion A, Macfarlane RM, Rose DH. Prospective study of aetiology and outcome of adult lower‐respiratory tract infections in the community. Lancet 1993;341:511‐4. - PubMed
Macfarlane 1994
Macfarlane 2001
Macfarlane 2002
Mainous 1996
-
- Mainous AG, Zoorob RJ, Hueston WJ. Current management of acute bronchitis in ambulatory care. Archives of Family Medicine 1996;5:79‐83. - PubMed
Metlay 1997a
-
- Metlay JP, Kapoor WN, Fine MJ. Does this patient have community‐acquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA 1997;278:1440‐5. - PubMed
Metlay 1997b
-
- Metlay JP, Stafford RS, Singer DE. National trends in the use of antibiotics by primary care physicians for adult patients with cough. Archives of Internal Medicine 1998;158:1813‐8. - PubMed
Meza 1994
-
- Meza RA, Bridges‐Webb C, Sayer GP, Miles DA, Traynor V, Neary S. The management of acute bronchitis in general practice: results from the Australian morbidity and treatment survey, 1990‐1991. Australian Family Physician 1994;23(8):1550‐3. - PubMed
Molstad 1992
-
- Molstad S, Arvidsson E, Eliasson I, Hovelius B, Kamme C, Schalén C. Production of beta‐lactamase in respiratory tract bacteria in children: relationship to antibiotic use. Scandinavian Journal of Primary Health Care 1992;10:16‐20. - PubMed
Oeffinger 1997
-
- Oeffinger KC, Snell LM, Foster BM, Panico KG, Archer RK. Diagnosis of acute bronchitis in adults: a national survey of family physicians. Journal of Family Practice 1997;45:402‐9. - PubMed
Petersen 2007
-
- Petersen I, Johnson AM, Islam A, Duckworth G, Livermore DM, Hayward AC. Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK General Practice Research Database. BMJ 2007;335:982. [DOI: 10.1136/bmj.39345.405243.BE] - DOI - PMC - PubMed
RevMan 2014 [Computer program]
-
- Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Robertson 1987
-
- Robertson PW, Goldberg H, Jarvie BH, Smith DD, Whybin LR. Bordetella pertussis infection: a cause of persistent cough in adults. Medical Journal of Australia 1987;146:522‐5. - PubMed
Smith 1986
-
- Smith JMB, Lockwood BM. Commensal or pathogen? The growing dilemma facing the general practitioner. New Zealand Medical Journal 1986;99:242‐3. - PubMed
Straand 1997
-
- Straand J, Skinio Rokstad K, Sandvik H. Prescribing systemic antibiotics in general practice: a report from the More and Romsdal Prescription Study. Scandinavian Journal of Primary Health Care 1998;16:121‐7. - PubMed
Stuart‐Harris 1965
Thom 1994
-
- Thom DH, Grayston JE, Campbell LA, Kuo CC, Diwan VK, Wang SP. Respiratory infection with Chlamydia pneumoniae in middle‐aged and older adult outpatients. European Journal of Clinical Microbiology and Infectious Diseases 1994;13:785‐92. - PubMed
van der Velden 2012
Verheij 1990
-
- Verheij TJM, Hermans J, Kaptein AA, Mulder JD. Acute bronchitis: general practitioners' views regarding diagnosis and treatment. Family Practice 1990;7:175‐80. - PubMed
References to other published versions of this review
Becker 1997
Fahey 1998
Fahey 2004
Smith 2009
Smith 2011
Smith 2014
Smucny 1998
-
- Smucny JJ, Becker LA, Glazier RH, McIsaac W. Are antibiotics effective treatment for acute bronchitis? A meta‐analysis. Journal of Family Practice 1998;47:453‐60. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous